Pulsed levosimendan therapy in the management of chronic end stage cardiac failure in 'adult congenital heart disease'

Int J Cardiol. 2015 Sep 15:195:283-4. doi: 10.1016/j.ijcard.2015.03.426. Epub 2015 Apr 1.

Authors

I Rafiq¹, Leisa J Freeman²

Affiliations

¹ Norfolk and Norwich University Hospital, United Kingdom.
² Norfolk and Norwich University Hospital, United Kingdom. Electronic address: [email protected].

PMID: 26056958
DOI: 10.1016/j.ijcard.2015.03.426

No abstract available

Keywords: Adult congenital heart disease; Cardiac failure; Therapeutics levosimendan.

Publication types

Case Reports
Letter

MeSH terms

Adult
Cardiac Surgical Procedures / adverse effects*
Cardiac Surgical Procedures / methods
Cardiotonic Agents / administration & dosage
Disease Progression
Female
Heart Defects, Congenital* / complications
Heart Defects, Congenital* / surgery
Heart Failure* / diagnosis
Heart Failure* / drug therapy
Heart Failure* / etiology
Heart Failure* / physiopathology
Heart Failure* / psychology
Humans
Hydrazones / administration & dosage*
Life Expectancy*
Male
Middle Aged
Postoperative Complications* / diagnosis
Postoperative Complications* / drug therapy
Postoperative Complications* / physiopathology
Postoperative Complications* / psychology
Pyridazines / administration & dosage*
Quality of Life*
Severity of Illness Index
Simendan
Treatment Outcome

Substances

Cardiotonic Agents
Hydrazones
Pyridazines
Simendan